# Treatment of Upper Extremity Deep-Vein Thrombosis

> **NCT00245856** · PHASE4 · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 67 (actual)

## Conditions studied

- Deep-Vein Thrombosis

## Interventions

- **DRUG:** Dalteparin sodium injection
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT00245856
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2009-03
- **Final completion:** 2011-12
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2013-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00245856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00245856, "Treatment of Upper Extremity Deep-Vein Thrombosis". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00245856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*